Early Intervention in Allergic Patients

Summary

As many as 250 million people suffer from allergic rhinitis in China, which has a large population, early use of drugs may help better control the symptoms.This study aimed to investigate the effects of early interventional treatment with the leukotriene receptor antagonist (LTRA) montelukast on seasonal allergic rhinitis.

Timeline

Start

2020-07-01

Primary completion

2020-09-30

Completion

2020-11-10

Drugs

Indications